Hansen Medical iss doch schei

Hansen Medical Inc Aktie ..buran und MfG

Satz 07-10-2013

Datum Erster Hoch Tief Schluss     Stücke Volumen
07.10.13 2,08 2,0885 2,00  2,01 $ 304.533 0,62 M

GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
08.10.13 2,00 2,07 1,96  1,97 $ 207.688 415 T

GrB

Frankfurt 1,47 € Nasdaq 2,21 $ buran und tau

Prev Close: 1.97
Open: N/A
Bid: N/A
Ask: 2.21 x 500
1y Target Est: 2.00
Beta: 1.36
Next Earnings Date: 4-Nov-13
Day's Range: N/A - N/A
52wk Range: 1.14 - 2.75
Volume: 0
Avg Vol (3m): 403,963
Market Cap: 133.47M
P/E (ttm): N/A
EPS (ttm): -0.45
Div & Yield: N/A (N/A)
finance.yahoo.com/q?s=HNSN&ql=1

Key Facts:
Founded in 2002
IPO November 2006
Headquartered in Mountain View, CA
Hansen Medical (NASDAQ: HNSN) the global leader in flexible robotics, was born from the vision of creating a new generation of advanced medical robotics. A generation that would empower and protect physicians while providing enhanced care for patients. The Sensei® Robotic Catheter System and Artisan™ Control Catheter is the first realization of this vision.

We believe the next-generation robotic catheter system, Sensei X, overcomes the limitations of manual technique by facilitating accurate positioning, manipulation, and stable control of catheter and catheter-based technologies during electrophysiology (EP) procedures. The system provides Instinctive Motion™ control and navigation of flexible catheters, resulting in enhanced access, stability, and control in complex interventional procedures. The key is our proprietary Instinctive Motion™ technology that accurately and responsively translates the physician’s hand movements at the motion controller to the robotically controlled steerable catheter in the patient’s anatomy.

This unique combination of technology and ergonomics helps physicians to establish a new standard of care by enabling a new class of percutaneous procedures using advanced electromechanical technology–creating a solution that we believe benefits patients and physicians.
www.hansenmedical.com/investor-relations/corporate-profile.php

www.hansenmedical.com/investor-relations/releases.php GrB

www.hansenmedical.com/investor-relations/sec-filings.php GrB

RTK 1,403 € RTP  -1,89 Pott -1,89%  ,GrB

Zeit  Kurs  Stück  
15:34:03 1,98 $  200  
15:30:00 1,98 $  2.261
__________________
GLÜCKWUNSCH

::::::::::::::: 1,98 $ +0,51% +0,01 $ In Euro: 1,4655 € | Nasdaq ,GrB

Preis pro share 2,01 $ Schleife 1.500 spread 2,03%

buran and GOoooooooo

RTK 1,91  $ RTP -3,05 EK 1,97 $ last shares 100 full 247.741 peak 1,98 ,GrB

Preis pro share 1,91 $ Schleife 1.200 spread 0,53% buran

Datum Erster Hoch Tief Schluss     Stücke Volumen
09.10.13 1,98 1,98 1,85  1,90 $ 254.698 484 T

GrB

Frankfurt 1,419 € Nasdaq 2,21 $ buran und MfG und tau

MEDICAL

SK 2,00 $ SKP +5,26 EK 1,90 $ last shares 600 full 114.918 peak 2,029

buran & Hansen,Die Börsen Medical KESSLERS

Datum Erster Hoch Tief Schluss     Stücke Volumen
14.10.13 2,00 2,05 1,971  2,04 $ 112.004 225 T

GrB

Zeit  Kurs  Stück  
15:49:57 1,47 €  1.500
__________________
GRATULATION

RTK 2,05 $ RTP -0,49 EK 2,06 $ last 100 full 135.006 peak 2,0612 ,GrB

Preis 2,06 $ Schleife 900 spread 0,49% / Dow 15.314 JOLLYS

Kosmonova buran und tau Und Dreimal Rosmaunde

RTK 2,09  $ RTP +0,72 EK 2,075 $ last 100 full 150.254 peak 2,10 ,GrB

:::::::::::::::::::: 2,09 $ +0,72% +0,015 $ In Euro: 1,5289 € | Nasdaq ,GrB

Preis 2,10 $ Schleife 20.700 spread 0,48% buran und tau und TRULLALA

Datum Erster Hoch Tief Schluss     Stücke Volumen
23.10.13 2,00 2,02 1,96  1,97 $ 211.177 419 T

GrB

::::::::: 1,99 $ +1,02% +0,02 $ In Euro: 1,4422 € | Nasdaq ,GrB

RTK 1,99  $ RTP +1,02%  EK 1,97 $ last 100 full 330.759 peak 2,05 buran

Preis 2,00 $ Schleife 2.800 spread 1,01%

buran & Hansen ..and good luck

Datum Erster Hoch Tief Schluss     Stücke Volumen
24.10.13 1,96 2,05 1,9599  2,00 $ 351.259 0,70 M

GrB

Preis pro Schein 1,81 $ Schleife 400 spread 0,56%

buran und MfG und Dreimal Rosamunde

Zeit   Kurs Stück
  15:30:00§1,87 $ 1.026
_____________________
GRATULATION

:::::::::::::::::: 1,363 € +3,10% +0,041 € ,GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
  05.11.13      1,87      1,88§1,77 1,86 $ 101.727 141 T

..ich das buran hör gerade nen interessanten Bericht im ISS Radio ..es geht um den neusten Fund der abhandenen Kunst Schätze ..also Gemälde und Bilder mit Taxe 1 Milliarde ..jener Wert wird enorm nach oben reviedieren durch den nun medialen Rummel in Gange kommt ..also Bilanz::: GELD

Kosmonova buran

..GRATULATION

RTP -2,67 EK 1,87 $ last shares 100 full RT 98.554 peak 1,87 ,GrB

and the physicians that treat and care for them, around the world.
www.hansenmedical.com/company/mission.php

To enable Cardiac Arrhythmia and Endovascular Procedures and to improve patient outcomes through the use of Intravascular Robotics
www.hansenmedical.com/company/mission.php

robotics, was born from the vision of creating a new generation of advanced medical robotics- a generation that would empower and protect physicians while providing enhanced care for patients. The Sensei® Robotic Catheter System and Artisan® Control Catheter used in electrophysiology procedures were the first realization of this vision. The Magellan™ Robotic System and Magellan™ Robotic Catheter are the next generation of intravascular robotics technology designed for peripheral vascular interventions. Hansen Medical headquarters are in Mountain View, California.

We believe that our new Magellan Robotic System has the potential to simplify and enhance catheter navigation and therapeutic interventions for peripheral vascular disease. The Magellan Robotic System, used in combination with the Magellan Robotic Catheter, will have the potential to enable physicians to cannulate target lesions through robotic control of the distal tips of sheath and leader catheters and through robotic control of guidewires.

We believe that our Sensei X Robotic Catheter System for electrophysiology procedures facilitate manipulation and stable control of catheter and catheter-based technologies during electrophysiology (EP) procedures. The System provides navigation of flexible catheters, resulting in stability, and control in interventional procedures. One key is our proprietary Instinctive Motion™ technology that accurately and responsively translates the physician’s hand movements at the motion controller to the robotically controlled steerable catheter in the patient’s anatomy.

At Hansen Medical, we are passionate about creating robotic solutions that provide physicians with a suite of tools for their procedural and therapeutic success. We believe that better tools will impact outcomes and patient care.
www.hansenmedical.com/company/profile.php

2012

   Magellan™ Robotic System FDA Clearance.

2011

   Magellan™ Robotic System CE Mark for peripheral vascular intervention.
   Partnership with Philips Healthcare on fiber optic shape sensing and localization technology.

2010

   First sale of Lynx® Irrigated Ablation Catheter in Europe
   First patients successfully treated with new flexible catheter vascular robotic system
   Hansen Medical Opens European Commercialization and Training Center
   Partnership with Philips Healthcare on the development of the vascular robotic system announced.

2009

   Sensei® X Robotic Catheter System FDA clearance & CE Mark
   Artisan Extend™ introduction in the U.S

2008

   CoHesion™ 3D Visualization Module FDA clearance & CE Mark

2007

   Sensei® Robotic Catheter System & Artisan® Control Catheter FDA clearance & CE Mark
   First Customer Shipment
   European Subsidiary opened in United Kingdom

2006

   IPO

2002

   Founded
www.hansenmedical.com/company/profile.php

nvestor Contacts:
Peter J. Mariani  
Chief Financial Officer  
Hansen Medical, Inc.  
650.404.5800     FTI Consulting, Inc.
Brian Ritchie
(212) 850-5683
Brian.Ritchie@fticonsulting.com

John Capodanno
212.850.5705
John.Capodanno@fticonsulting.com

88 Pine Street, 32nd Floor
New York, NY 10005

@Kosmonova buran,ISS
www.hansenmedical.com/investor-relations/...ct-information.php

Event Details
     Title§Hansen Medical Inc at Barclays Select Growth Conference
Date and Time Monday, November 18, 2013 9:05 a.m. ET  
  Location§New York City, NY  US
www.hansenmedical.com/investor-relations/...-recent-events.php

  08/16/13         3§Initial filing by director officer or owner of more than ten percent. 3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF
  08/16/13§SC 13D Filing by person(s) reporting owned shares of common stock in a public company >5% Other Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF
  08/14/13         D               Other§Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF
  08/12/13         4§Statement of changes in beneficial ownership of securities 3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF
www.hansenmedical.com/investor-relations/sec-filings.php

Datum Erster Hoch Tief Schluss     Stücke Volumen
  15.11.13      1,82      1,90§1,795 1,85 $ 273.038 0,51 M

GrB

Hansen Medical, Inc. (NASDAQ: HNSN)

Corporate Headquarters:
800 E Middlefield Rd.
Mountain View, Calif., 94043
650.404.5800
www.hansenmedical.com

          §European Subsidiary:
Hansen Medical UK Ltd.
30 Eastbourne Terrace
Paddington, London
W2 6LE United Kingdom
+44 207 393 1900

Founded: 2002

IPO: November 2006

Business Objective: Hansen Medical, Inc. (NASDAQ: HNSN) was founded in 2002 to develop products and technology using robotics for the accurate positioning, manipulation and stable control of catheters and catheter-based technologies.

Total Number of Employees as of July 1, 2011: Approximately 175

Products and Intended Use:

   The Magellan™ Robotic System: The Magellan Robotic System and the NorthStar™ Robotic Catheter were created to improve the ability of physicians to efficiently perform endovascular procedures, and to enable new procedures, while exposing the physician to less radiation. The system will enable remote and predictable manipulation of low-profile robotically steerable catheters. The catheters are designed to simplify catheter navigation and therapeutic intervention with minimal learning curve. The Magellan system was CE Marked in the European Union in July 2011 and received FDA clearance in June 2012. The indication for use is to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices.


   The Sensei® X Robotic System: The Sensei X Robotic Catheter System and Artisan® Control Catheter allow physicians to instinctively navigate flexible catheters with great stability and control during interventional procedures. The Sensei X system was cleared by the US FDA and CE Marked in 2009 for manipulation and control of certain mapping catheters in electrophysiology (EP) procedures. The Sensei system was cleared by the US FDA and CE Marked in 2007 for use during EP procedures, such as guiding catheters in the treatment of atrial fibrillation.

Media Resource:
Bruce J Barclay, president and CEO
Hansen Medical

The safety and effectiveness of the Sensei® X Robotic Catheter System for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation, have not been established.

The NorthStar™ Robotic Catheter - Not yet CE marked.
Magellan™ Robotic System and NorthStar™ Robotic Catheter - 510(k) Pending.  Not available for sale in the U.S.

Forward-Looking Statements
This fact sheet contains forward-looking statements regarding, among other things, statements relating to goals, plans, objectives, milestones and future events. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including statements containing the words “plan,” “expects,” “potential,” “believes,” goal,” “estimate,” and similar words. These statements are based on the current estimates and assumptions of our management as of the date of this press release and are subject to risks, uncertainties, changes in circumstances and other factors that may cause actual results to differ materially from the information expressed or implied by forward-looking statements made in this press release. Examples of such statements include statements about, the potential benefits of our Magellan Robotic System on the vascular procedures and the timing and results of commercializing our Magellan Robotic System. Important factors that could cause actual results to differ materially from those indicated by such forwardlooking statements include, among others: engineering, regulatory and sales challenges in developing new products and entering new markets; potential safety and regulatory issues that could slow or suspend our sales; the uncertain timelines, costs and results of pre-clinical and clinical trials; the rate of adoption of our systems and the rate of use of our catheters; the scope and validity of intellectual property rights applicable to our products; competition from other companies; our ability to recruit and retain key personnel; our ability to maintain our remedial actions over previously reported material weaknesses in internal controls over financial reporting; the effect of credit, financial and economic conditions on capital spending by our potential customers; our ability to manage expenses and obtain additional financing; and other risks more fully described in the "Risk Factors" section of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2012 filed with the SEC on May 7, 2012 and the risks discussed in our other reports filed with the SEC. Given these uncertainties, you should not place undue reliance on the forward-looking statements in this press release. We undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes available.

Hansen Medical, Heart Design (Logo), Hansen Medical (with Heart Design), and Sensei are registered trademarks, and Magellan is a trademark of Hansen Medical, Inc. in the United States and other countries.
Media and Investor Contacts:

Brian Ritchie
212.850.5683
brian.ritchie@fticonsulting.com

John Capodanno
212-850-5705
john.capodanno@fticonsulting.com
www.hansenmedical.com/investor-relations/...tor-fact-sheet.php

Proxy Materials for 2013 Annual Meeting of Stockholders
www.hansenmedical.com/investor-relations/proxy-materials.php

  07/31/13§Hansen Medical Enters Into Agreement With Investors to Receive up to $93 Million in Equity Financing Printer Friendly Version
  07/23/13§Hansen Medical Reports Preliminary Second Quarter 2013 Results Printer Friendly Version
  07/17/13§Marjorie Bowen Appointed to Hansen Medical's Board of Directors Printer Friendly Version
  07/17/13§Hansen Medical and Philips Reinforce Collaboration in Robotic Systems for Endovascular Interventions Printer Friendly Version
  07/10/13§Will Weinstein Appointed to Hansen Medical's Board of Directors Printer Friendly Version
  07/10/13§Hansen Medical to Replace Current Debt Facility With New $33 Million, Interest-Only Debt Facility Through 2017 Printer Friendly Version
  06/26/13§Hansen Medical Announces Initiation of Sell-Side Coverage by Cowen and Company Printer Friendly Version
  06/25/13§Hansen Medical Announces Initiation of Sell-Side Coverage by Wm Smith & Co. Printer Friendly Version
  05/29/13§Hansen Medical Announces U.S. Food and Drug Administration Conditionally Approves New Study Design Evaluating the Use of the Artisan(R) Family of Control Catheters With the Sensei(R) X Robotic System for the Treatment of Atrial Fibrillation Printer Friendly Version
  05/23/13§Hansen Medical to Exhibit Magellan(TM) Robotic System at 2013 Vascular Annual Meeting(R) of the Society for Vascular Surgery Printer Friendly Version
  05/08/13§Hansen Medical Reports First Quarter 2013 Results Printer Friendly Version
  05/08/13§Hansen Medical Announces Agreement in Principle to Settle Securities Class Action Printer Friendly Version
  05/07/13§Hansen Medical's Magellan(TM) Robotic System Scheduled to Be Utilized in Five Live Cases at EuroPCR 2013 Printer Friendly Version
  05/06/13§Hansen Medical to Exhibit Magellan(TM) Robotic System at 8th Annual European Symposium of Vascular Biomaterials in France Printer Friendly Version
  04/30/13§Pre-Clinical Study and Initial Clinical Experience Highlight Potential Benefits of Hansen Medical's Robotic Technology in Treating Carotid Arteries Printer Friendly Version
  04/30/13§Hansen Medical Announces First Quarter 2013 Results Conference Call Printer Friendly Version
  04/29/13§Hansen Medical to Highlight Sensei(R) X Robotic Catheter System and New Artisan Extend(R) Control Catheter at Heart Rhythm Society Annual Meeting Printer Friendly Version
  04/08/13§French National Television Newscast Highlights Endovascular Procedure Featuring Hansen Medical's Magellan(TM) Robotic System Printer Friendly Version
  04/03/13§The Heart and Vascular Center Bad Bevensen Treats First Patients in Germany With Hansen Medical's Magellan(TM) Robotic System Printer Friendly Version
  04/01/13§Hansen Medical to Exhibit Its Magellan(TM) Robotic System at 35th Annual Charing Cross International Symposium Printer Friendly Version
  04/01/13§Hansen Medical Announces the Filing of 30 New U.S. Patent Applications Related to Flexible Medical Robotics Printer Friendly Version
  02/27/13§Hansen Medical Reports Full Year 2012 and Fourth Quarter Results Printer Friendly Version
  02/18/13§Hansen Medical to Present at 33rd Annual Cowen Healthcare Conference Printer Friendly Version
  02/14/13§Hansen Medical Appoints Will Sutton as Chief Operating Officer Responsible for Engineering and Manufacturing Printer Friendly Version
  02/13/13§Hansen Medical Announces Fourth Quarter and Full-Year 2012 Results Conference Call Printer Friendly Version
  01/23/13§Hansen Medical's Magellan(TM) Robotic System Utilized in Two Successful Live Cases at the 25th Annual International Symposium on Endovascular Therapy Printer Friendly Version
  01/16/13§Hansen Medical Names Robert Cathcart Senior Vice President of Global Sales Printer Friendly Version
  01/15/13§Hansen Medical to Exhibit Magellan(TM) Robotic System at 25th Annual International Symposium on Endovascular Therapy
www.hansenmedical.com/investor-relations/releases.php

SK 1,85 $ SKP +0,00 Pott -4,14% ,GrB

   Founded in 2002
   IPO November 2006
   Headquartered in Mountain View, CA

Hansen Medical (NASDAQ: HNSN) the global leader in flexible robotics, was born from the vision of creating a new generation of advanced medical robotics. A generation that would empower and protect physicians while providing enhanced care for patients. The Sensei® Robotic Catheter System and Artisan™ Control Catheter is the first realization of this vision.

We believe the next-generation robotic catheter system, Sensei X, overcomes the limitations of manual technique by facilitating accurate positioning, manipulation, and stable control of catheter and catheter-based technologies during electrophysiology (EP) procedures. The system provides Instinctive Motion™ control and navigation of flexible catheters, resulting in enhanced access, stability, and control in complex interventional procedures. The key is our proprietary Instinctive Motion™ technology that accurately and responsively translates the physician’s hand movements at the motion controller to the robotically controlled steerable catheter in the patient’s anatomy.

This unique combination of technology and ergonomics helps physicians to establish a new standard of care by enabling a new class of percutaneous procedures using advanced electromechanical technology–creating a solution that we believe benefits patients and physicians.
www.hansenmedical.com/investor-relations/corporate-profile.php

Exchange NASDAQ (US Dollar)
     Price§$1.85
Change (%) Stock is Up 0.03 (1.65%)
    Volume§273,038
Today's Open $1.82
Previous Close $1.82
Intraday High $1.90
Intraday Low $1.80
52 Week High $2.75
52 Week Low $1.14
Data as of 11/15/13 4:00 p.m. ET
www.hansenmedical.com/investor-relations/stock-quote.php

Handelsplatz Geld-Stk. Geld Geld-Brief Brief Brief-Stk. Spread Zeit

Frankfurt 4.600 1,32 € 1,346 € 4.500 1,97% 11:19:00

Nasdaq 300 1,76 $ 2,21 $ 500 25,57% 10:00:01

Kosmonova buran und MfG und Dreimal Rosamunde

                 100          §
  16:57:12§1,77 $
                 400          §
  16:57:12§1,77 $
               1.383          §
  16:57:12§1,77 $
                 258          §
  16:57:12§1,77 $
                 300          §
  16:57:12§1,77 $
                 100          §
  16:57:12§1,77 $
                 100          §
  16:54:55§1,77 $
                 100          §
  16:53:55§1,77 $
                 100          §
  16:50:09§1,78 $
                 400          §
  16:50:09§1,78 $
                 100          §
  16:50:09§1,78 $
               1.000          §
  16:50:09§1,78 $
                 100          §
  16:50:09§1,78 $
                 600          §
  16:50:09§1,78 $
                 100          §
  16:50:09§1,78 $
                 100          §
  16:50:08§1,78 $
                 100          §
  16:50:08§1,79 $
               9.400          §
  16:50:08§1,79 $
               4.748          §
  16:50:08§1,79 $
                 100          §
  16:50:08§1,79 $
                 200          §
  16:50:08§1,79 $
                 100          §
  16:50:08§1,79 $
               8.000          §
  16:50:08§1,79 $
                 100          §
  16:49:29§1,79 $
                 100          §
  16:48:45§1,80 $
                 100          §
  16:46:41§1,79 $
                 100          §
  16:46:38§1,795 $
                 100          §
  16:45:11§1,79 $
                 100          §
  16:44:24§1,80 $
                 200          §
  16:42:11§1,795 $
                 100          §
  16:42:11§1,7995 $
               1.500          §
  16:40:58§1,79 $
                 100          §
  16:39:51§1,80 $
                 200          §
  16:38:39§1,7901 $
               3.800          §
  16:38:30§1,79 $
                 400          §
  16:38:19§1,79 $
               3.800          §
  16:38:09§1,79 $
                 100          §
  16:37:29§1,80 $
                 100          §
  16:36:48§1,79 $
                 100          §
  16:32:47§1,79 $
                 100          §
  16:27:34§1,79 $
                 100          §
  16:26:02§1,80 $
                 100          §
  16:25:59§1,79 $
                 100          §
  16:25:04§1,79 $
                 100          §
  16:21:19§1,79 $
                 100          §
  16:20:32§1,7999 $
               5.000          §
  16:17:42§1,79 $
                 100          §
  16:14:36§1,80 $
                 100          §
  16:14:14§1,79 $
                 100          §
  16:10:50§1,79 $
                 100§
16:09:25 1,79 $
                 100          §
  16:08:20§1,79 $
                 100          §
  16:06:58§1,80 $
                 100          §
  16:05:41§1,7994 $
                 100          §
  16:03:43§1,80 $
                 100          §
  16:03:34§1,80 $
               1.275          §
  15:56:25§1,80 $
                 700          §
  15:55:31§1,80 $
                 100          §
  15:53:40§1,79 $
               1.000          §
  15:53:13§1,79 $
                 300          §
  15:53:13§1,793 $
                 300          §
  15:51:16§1,79 $
               1.000          §
  15:49:35§1,80 $
               1.000          §
  15:49:15§1,80 $
                 100          §
  15:49:07§1,80 $
                 100          §
  15:49:02§1,79 $
                 100          §
  15:49:02§1,80 $
                 300          §
  15:49:02§1,79 $
                 900          §
  15:48:22§1,7899 $
               1.000          §
  15:46:40§1,77 $
                 900          §
  15:46:34§1,78 $
                 400          §
  15:46:33§1,78 $
                 400          §
  15:46:10§1,80 $
              17.200          §
  15:46:09§1,78 $
                 700          §
  15:46:09§1,781 $
               1.200          §
  15:46:09§1,78 $
                 200          §
  15:46:08§1,799 $
               7.800          §
  15:43:00§1,80 $
               8.771          §
  15:42:28§1,81 $
                 100          §
  15:36:12§1,8199 $
                 150          §
  15:30:00§1,81 $
                 100          §
  15:30:00§1,80 $
          §584

GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
19.11.13 1,80 1,8199 1,76   1,78 $ 297.165 0,53 M

GrB

Zeit   Kurs Stück
12:31:43 1,42 € 1.000
____________________
GRATULATION

          §100
17:54:11 1,8699 $
          §2.150
17:41:46 1,86 $
          §100
17:37:35 1,87 $
          §100
17:36:07 1,86 $
          §1.400
17:34:15 1,86 $
          §100
17:32:00 1,87 $
          §100
17:29:28 1,87 $
          §1.500
17:24:35 1,87 $
          §100
17:19:16 1,86 $
          §700
17:12:44 1,87 $
          §100
17:12:39 1,87 $
          §100
17:12:33 1,87 $
          §100
17:04:27 1,85 $
          §100
16:54:56 1,84 $
          §100
16:51:51 1,84 $
          §200
16:46:34 1,84 $
          §100
16:45:55 1,83 $
          §100
16:42:29 1,836 $
          §1.050
16:42:06 1,86 $
          §100
16:37:38 1,8292 $
          §700
16:37:38 1,82 $
          §2.300
16:37:33 1,83 $
          §100
16:37:00 1,83 $
          §100
16:37:00 1,82 $
          §200
16:36:59 1,82 $
          §3.000
16:36:59 1,8201 $
          §519
16:36:59 1,82 $
          §100
16:36:59 1,8201 $
          §100
16:36:59 1,82 $
          §200
16:36:59 1,83 $
          §100
16:36:59 1,84 $
          §600
16:36:59 1,8401 $
          §300
16:36:59 1,84 $
          §100
16:35:52 1,86 $
          §300
16:35:41 1,88 $
          §100
16:32:33 1,88 $
          §100
16:29:40 1,88 $
          §100
16:29:08 1,86 $
          §100
16:23:51 1,87 $
          §100
16:20:19 1,86 $
          §100
16:17:57 1,838 $
          §3.000
16:17:43 1,85 $
          §2.500
16:17:43 1,86 $
          §100
16:17:43 1,87 $
          §1.520
16:15:31 1,88 $
          §100
16:14:56 1,88 $
          §100
16:13:51 1,85 $
          §4.800
16:11:03 1,85 $
          §9.216
16:08:45 1,87 $
          §100
16:05:51 1,86 $
          §100
16:05:50 1,86 $
          §300
16:05:41 1,8501 $
          §1.000
16:00:44 1,88 $
          §100
15:58:52 1,86 $
          §600
15:58:52 1,85 $
          §100
15:58:52 1,845 $
          §100
15:58:36 1,84 $
          §200
15:53:27 1,8497 $
          §600
15:53:27 1,85 $
          §800
15:52:15 1,842 $
          §100
15:49:02 1,84 $
          §100
15:48:02 1,831 $
          §200
15:44:19 1,81 $
          §100
15:30:00 1,83 $
          §2.762
GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
22.11.13 1,87 1,87 1,81   1,84 $ 106.735 196 T

GrB

Zeit    Kurs Stück
  16:10:49§1,388 € 1.000
__________________
GRATULATION

SK 1,85  $ RTP +0,54 EK 1,84 $ last shares 2.721 full 164.676 peak 1,87 buran und MfG und danke und schüddelböööööön

Datum Erster Hoch Tief Schluss     Stücke Volumen
  25.11.13     1,388     1,388§1,388 1,388 € 1.000 1.388

GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
  25.11.13      1,83      1,87§1,81 1,85 $ 164.676 303 T

GrB

Preis pro Anteilsschein 1,384 € Schleife 8.672 spread 1,99% buran und MfG und Holla Die Waldfee

       100          §
  19:20:35§1,8418 $
       100          §
  18:56:26§1,84 $
       100          §
  18:54:26§1,85 $
       300          §
  18:53:54§1,85 $
     1.100          §
  18:53:54§1,845 $
       100          §
  18:53:54§1,85 $
       100          §
  18:48:56§1,84 $
       100          §
  18:47:48§1,841 $
       100          §
  18:38:22§1,841 $
       100          §
  18:32:50§1,84 $
       100          §
  18:29:03§1,841 $
       100          §
  18:19:39§1,841 $
       100          §
  18:18:26§1,84 $
       400          §
  18:16:26§1,84 $
       300          §
  18:16:19§1,8449 $
     3.800          §
  18:16:19§1,85 $
     1.400          §
  18:10:28§1,85 $
       100          §
  18:08:41§1,85 $
       550          §
  18:05:37§1,8503 $
       500          §
  18:02:36§1,85 $
       400          §
  18:01:59§1,85 $
       100          §
  18:01:55§1,85 $
       400          §
  17:58:00§1,859 $
       240          §
  17:53:24§1,8503 $
       100          §
  17:49:50§1,8599 $
     5.000          §
  17:48:46§1,85 $
     2.000          §
  17:45:41§1,85 $
     1.300          §
  17:45:37§1,85 $
       400          §
  17:45:03§1,8501 $
       100          §
  17:34:55§1,85 $
       100          §
  17:34:25§1,859 $
       250          §
  17:33:43§1,84 $
     2.500          §
  17:31:29§1,8548 $
       305          §
  17:30:42§1,85 $
     8.500          §
  17:30:18§1,85 $
     5.000          §
  17:29:50§1,85 $
       200          §
  17:29:45§1,846 $
       100          §
  17:29:45§1,84 $
       100          §
  17:29:45§1,85 $
       200          §
  17:29:45§1,84 $
       100          §
  17:29:45§1,85 $
     1.800          §
  17:28:47§1,85 $
       100          §
  17:21:51§1,85 $
       100          §
  17:20:28§1,85 $
       100          §
  17:13:17§1,851 $
     1.000          §
  17:12:30§1,85 $
       100          §
  17:05:23§1,85 $
       100          §
  17:04:49§1,85 $
       100          §
  17:01:11§1,8501 $
       300          §
  16:57:17§1,85 $
       100          §
  16:56:39§1,86 $
     1.300          §
  16:56:15§1,85 $
       700          §
  16:56:15§1,8501 $
       400          §
  16:56:15§1,85 $
       100          §
  16:49:48§1,85 $
       100          §
  16:31:48§1,8552 $
       400          §
  16:24:05§1,852 $
       960          §
  16:22:02§1,86 $
       500          §
  16:21:14§1,86 $
     1.700          §
  16:21:12§1,8585 $
       300          §
  16:19:13§1,8501 $
     3.000          §
  16:14:35§1,8401 $
    10.000          §
  16:10:55§1,85 $
       100          §
  16:09:58§1,85 $
       100          §
  16:09:03§1,85 $
       800          §
  16:08:01§1,85 $
       300          §
  16:05:53§1,85 $
       600          §
  16:05:21§1,85 $
     1.300          §
  16:04:07§1,85 $
     1.400          §
  16:02:22§1,85 $
       800          §
  16:00:30§1,841 $
       100          §
  15:59:37§1,84 $
       200          §
  15:52:01§1,85 $
       300          §
  15:47:37§1,85 $
     1.500          §
  15:47:35§1,86 $
     2.300          §
  15:47:35§1,84 $
       100          §
  15:46:42§1,84 $
       100          §
  15:39:45§1,854 $
       110          §
  15:39:44§1,86 $
       110          §
  15:36:13§1,84 $
       200          §
  15:34:53§1,85 $
       583          §
  15:30:00§1,84 $
6.750

GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
  27.11.13      1,87      1,91§1,84 1,89 $ 194.993 358 T

GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
  06.12.13      1,81      1,86§1,73 1,815 $ 261.908 469 T

..steuert volle Wucht inne kleine Bucht ..ach da naht auch schon am Strande eine geile Weiberbande ..festgelegt in dicken Stricken musste er sie alle *piep*

buran & Hansen,Die Börsen Kapitanos

Zeit      Kurs Stück
  08:58:18§1,315 € 1.000
__________________
GRATULATION

SK 1,77  $ SKP -2,48 EK 1,815 $ last shares 1.071 full 100.409 peak 1,82

buran und MfG und danke und FREIHEIT FÜR NELSON MANDELA

SK 1,88  $ SKP +6,82 EK 1,76 $ last shares 10.515 full 213.790 peak 1,90

buran,Die Börsen Mutti Ist Stolz Auf Euch

::::::::::: 1,88 $ +6,82% +0,12 $
In Euro: 1,3754 € | Nasdaq, 10.01.14::::::::: komm gib mir Deine Hand ..ich das buran zeig Dir das Börsen Wunderland ..::hopshopshopshopshopshopshopshopshops

Kosmonova buran,Die Börsen Wunder Alice

Datum Erster Hoch Tief Schluss     Stücke Volumen
  17.01.14      2,08      2,08§1,99 2,05 $ 300.920 0,60 M

GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
  16.01.14     1,474     1,548§1,474 1,548 € 1.700 2.586

GrB

RT Preis pro Anteilsschein 1,536 € Schleife 7.816 spread 1,92% buran und MfG und bummmswalleraaaaa

buran,Der Börsen Hansen Ticker FFM Karussellbremser

  13.02.14      2,54      2,64§2,47 2,59 $ 755.316 1,93 M
  12.02.14      2,49      2,56§2,31 2,55 $ 1.256.271 3,02 M
  11.02.14      2,38      2,89§2,38 2,51 $ 6.503.612 17,1 M
  10.02.14      2,23      2,25§2,18 2,23 $ 104.209 228 T
  07.02.14      2,24      2,29§2,20 2,21 $ 109.513 237 T
  06.02.14      2,27      2,27§2,20 2,25 $ 127.716 271 T
  05.02.14      2,25      2,27§2,12 2,25 $ 209.506 450 T
  04.02.14      2,24      2,35§2,20 2,24 $ 186.559 415 T
  03.02.14      2,26      2,29§2,14 2,24 $ 332.523 0,72 M

GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
24.03.14 2,51 2,52 2,30  2,41 $ 678.475 1,62 M

GrB

schon...

hab mir auch mal wieder einige Stücklein geholt.

Gruß

Datum Erster Hoch Tief Schluss     Stücke Volumen
  31.03.14      2,43      2,65§2,43 2,60 $ 844.838 2,13 M

buran und MfG und danke und weitermachen und FÄDDSCH ..::hopshopshopshops

::::::::: 1,005 € +0,20% +0,002 €:::::: Euer König Hansen hat jene Schluss Lampe zu Ticker wiedermal in GRÜN Kund getan ..::hopshopshops HALLO

buran du alter hansen jâger

ich bin jetzt auch endlich dabei, leider zu spât und zu schlechterem kurs,

aber endlich um die 50k geshortet

wer noch?

das war ja ein schneller gewinn. 10 prozent in 2 tagen. haelfte der position wird glattgestellt. und warte auf neueinstieg bei 1.30$
es heisst hansen medical sei bald bankrott. zu hohe schulden, kein cash, dazu werden die aktien staendig verwaessert. bei hansen sind die lichter aus, alle wichtigen patente wurden an intuit surgical verscherbelt

Datum Erster Hoch Tief Schluss     Stücke Volumen
  06.08.14      1,19      1,20§1,16 1,18 $ 155.154 183 T

GrB

was spakkst du sohn

-  Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the second quarter of fiscal year 2014 ended June 30, 2014.finance.yahoo.com/news/...eports-second-quarter-200500394.html

Revenues of $6.9 million, up 106% year-over-year.
Commercialized and sold four robotic systems (3 Magellan™ Robotic System and 1 Sensei® X Robotic Catheter System) compared to one robotic system in the second quarter of 2013. As a reminder, the Company uses the term "commercialized" to refer to revenue-generating system transactions, including rental transactions.
Converted a previously commercialized Magellan System from a rental to a sale.
Commercialized 928 catheters, compared with 685 catheters sold in first quarter of fiscal year 2014 and 875 catheters sold during the second quarter of fiscal year 2013; representing sequential growth of approximately 35%, with 6% growth year over year, respectively.
The Company signed an exclusive distribution agreement with Japanese distributor Adachi Co, Ltd.
Initiated a series of procedures with the Magellan 6Fr catheter in targeted therapeutic areas including women's and men's health, cancer treatment, and limb salvage.finance.yahoo.com/news/...eports-second-quarter-200500394.html

announced the signing of an exchange agreement with certain of its holders of outstanding warrants, previously issued and announced in August 2013. Pursuant to the exchange agreement, and following the satisfaction of customary closing conditions expected in August 2014, the Company will exchange approximately 90% of the outstanding Series B and Series C warrants, which currently carry an exercise price of $1.50 and $2.00, respectively, for a Series B/C exchange warrants at an exercise price equal to the Company's NASDAQ closing price on July 29, 2014 of $1.13. Pending satisfaction of certain closing conditions, the Series B/C exchange warrants to purchase an aggregate of 20,442,346 shares of common stock will be issued and will be subject to mandatory exercise within 14 days of issuance and will result in gross proceeds to the Company of approximately $23.1 million. In addition, in connection with this transaction, pending the satisfaction of certain closing conditions, the Company will issue to the participating holders an additional aggregate of 6,286,023 Series D warrants with an exercise price of $1.13 and an expiration date of August 2019, which if fully-exercised would yield additional gross proceeds to the Company of approximately $7.1 million. The Series B and Series C warrants previously carried an expiration date of August 2015 and the remaining 2,321,876 warrants not exchanged in the transaction will remain outstanding until their exercise or expiration. The Company is not obligated to pay any placement fees or commissions in connection with the exchange transaction.finance.yahoo.com/news/...eports-second-quarter-200500394.html

through the first half of fiscal year 2014," said Cary Vance, Hansen Medical's Chief Executive Officer. "Everything I have learned to-date supports my belief that the Company has an innovative portfolio of intravascular robotic technology, which improves patient outcomes in cardiac arrhythmia and endovascular procedures. Since joining the Company in May, I have been focused on global commercialization efforts and continuing to deliver an excellent customer experience to each of our Hansen customers, and look forward to sharing my vision for the Company in the coming quarters."finance.yahoo.com/news/...eports-second-quarter-200500394.html

June 30, 2014 increased 106% to $6.9 million, compared to revenue of $3.3 million in the same period in 2013. The Company commercialized and sold four robotic systems in the quarter (3 Magellan System and 1 Sensei System) and converted an additional Magellan System from a rental to a sale. The Company uses the term "commercialized" to refer to revenue-generating system transactions, including rental transactions. The Company sold 928 catheters in the second quarter of fiscal 2014, up 6% year-over-year. Physicians performed an estimated 868 robotic procedures in the second quarter of 2014, compared to 864 robotic procedures in the same period last year.finance.yahoo.com/news/...eports-second-quarter-200500394.html

of fiscal year 2014 increased 230% to $1.9 million, or 28% of sales, compared to $0.6 million, or 17% of sales, in the same period prior year. The improvement in gross margin in the current year second quarter was driven primarily by increased system sales, compared to the prior year period.finance.yahoo.com/news/...eports-second-quarter-200500394.html

for the second quarter of fiscal year 2014 were $4.8 million, compared to $4.5 million for same period in 2013. The increase of $0.3 million is primarily due to an increase in clinical trial expenses as we work to expand the application of our robotic platform in women's and men's health, cancer, and lower limb treatments.finance.yahoo.com/news/...eports-second-quarter-200500394.html

for the second quarter were $8.1 million, compared to $8.6 million for the same period of 2013. The decrease of $0.5 million year-over-year is primarily due to a decrease in legal expenses and other corporate matters, partially offset by an increase in sales and marketing expenses.finance.yahoo.com/news/...eports-second-quarter-200500394.html

was $12.3 million, or $0.11 per share, compared to a net loss of $13.4 million, or $0.20 per share, in the second quarter of 2013. Weighted average shares outstanding used to compute diluted net loss per share were 112.0 million for the second quarter of fiscal 2014, compared to 67.6 million in the second quarter of fiscal 2013. finance.yahoo.com/news/...eports-second-quarter-200500394.html

total revenue increased 68% to $10.6 million, compared to $6.3 million in the same period last year. Net loss for the first six months of 2014 was $26.7 million, or $0.25 per share, compared to a net loss of $30.6 million, or $0.45 per share, last year. Weighted average shares outstanding used to compute diluted net loss per share were 107.7 million for the six month period ending June 30, 2014, compared to 67.5 million in the same period last year.finance.yahoo.com/news/...eports-second-quarter-200500394.html

cash equivalents, short-term investments and restricted cash balances were $32.2 million, compared to $38.4 million as of March 31, 2014, and $35.3 million as of December 31, 2013.finance.yahoo.com/news/...eports-second-quarter-200500394.html

the second quarter 2014 results and host a conference call on July 31, at 5:00 p.m. ET (2:00 p.m. PT) at which point the Company will discuss in more detail the results of the quarter and other recent business highlights. Investors are invited to listen to the call live via the Internet using the link available within the "Investor Relations" section of Hansen Medical's website at www.hansenmedical.com. Additionally, participants can dial into the live conference call by calling 877-419-6603 (719-325-4879 for international callers) and referencing the participant code 7639526. An audio replay of the webcast will be available approximately one hour after the completion of the conference call through July 14, 2014 by calling 877-870-5176 (858-384-5517 for international callers) and entering the access code 7639526. finance.yahoo.com/news/...eports-second-quarter-200500394.html

California, is a global leader in intravascular robotics, developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The Company's Magellan™ Robotic System, 9Fr Magellan™ Robotic Catheter, Magellan™ 6Fr Robotic Catheter, and related accessories are intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Magellan 9Fr Robotic Catheter has undergone both CE marking and 510(k) clearance and is commercially available in the European Union, and the U.S. The Magellan 6Fr Robotic Catheter has undergone 510(k) clearance in the U.S. and is in limited release for the next several months in anticipation of more wide-scale commercial availability later in 2014. In the European Union, the Company's Sensei® X Robotic Catheter System and Artisan® and Artisan Extend® Control Catheters are cleared for use during electrophysiology (EP) procedures, such as guiding catheters in the treatment of atrial fibrillation (AF), and the Lynx® Robotic Ablation Catheter is cleared for the treatment of AF. This robotic catheter system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. In the U.S., the Company's Sensei X Robotic Catheter System and Artisan and Artisan Extend Control Catheters are cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in EP procedures. In the U.S., the Sensei X Robotic Catheter System is not approved for use in guiding ablation procedures; this use remains experimental. The U.S. product labeling therefore provides that the safety and effectiveness of the Sensei X Robotic Catheter System and Artisan and Artisan Extend Control Catheter for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including AF, have not been established. Additional information can be found at www.hansenmedical.com.

statements regarding, among other things, statements relating to goals, plans, objectives, milestones and future events. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including statements containing the words "plan," "expects," "potential," "believes," "goal," "estimate," "anticipates," and similar words. These statements are based on the current estimates and assumptions of our management as of the date of this press release and are subject to risks, uncertainties, changes in circumstances and other factors that may cause actual results to differ materially from the information expressed or implied by forward-looking statements made in this press release. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, among others: factors relating to engineering, regulatory, manufacturing, sales and customer service challenges in developing new products and entering new markets; potential safety and regulatory issues that could slow or suspend our sales; the effect of credit, financial and economic conditions on capital spending by our potential customers; the uncertain timelines for the sales cycle for newly introduced products; the rate of adoption of our systems and the rate of use of our catheters; the scope and validity of intellectual property rights applicable to our products; competition from other companies; our ability to recruit and retain key personnel; our ability to manage expenses and cash flow, and obtain additional financing; and other risks more fully described in the "Risk Factors" section of our Quarterly Report on Form 10-Q for the year ended March 31, 2014 filed with the SEC on May 9, 2014 and the risks discussed in our other reports filed with the SEC. Given these uncertainties, you should not place undue reliance on the forward-looking statements in this press release. We undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes available.finance.yahoo.com/news/...eports-second-quarter-200500394.html

"Hansen Medical (with Heart Design)," "Heart Design (Logo)," "Sensei," "Lynx," "Artisan," "Instinctive Motion," "Fine Force Technology," "IntelliSense" are registered trademarks, and "Magellan" and "Hansen Medical Magellan" are trademarks of Hansen Medical, Inc. in the U.S. and other countries.finance.yahoo.com/news/...eports-second-quarter-200500394.html

Investor
Christopher Lowe
Interim Chief Financial Officer
Hansen Medical, Inc.
650.404.5800

Westwicke Partners, LLC.
Mark Klausner or Mike Piccinino, CFA
443.213.0500
Email Contact

@Kosmonova buran,Orbit ISS
finance.yahoo.com/news/...eports-second-quarter-200500394.html

wow super danke wegen deinem gespamme haben meine shorts jetzt gelitten

Nasdaq Buch
http://www.ariva.de/hansen_medical_inc-aktie/...nd_sales?boerse_id=40 Gr

Buch dazu
http://www.ariva.de/hansen_medical_inc-aktie/...nd_sales?boerse_id=40 GrB

Preis pro share 1,26 $ Schleife 800 spread 0,80% buran und MfG andddd goooooooooo ..::hopshops HALLO ..datt muss datt Boot aushalten ..::hopshops

Kapitano buran

..Grüsse und Küsse ..Dein MARIO ..büschen schwul fetzt immer ..::hopshops HALLO ...Mehr anzeigen

Hansen Medical Inc Aktie (WKN A0LHLD, ISIN US4113071017): Aktienkurs und Übersicht - ARIVA.DE
www.ariva.de
Zu der Hansen Medical Inc Aktie (WKN A0LHLD, ISIN US4113071017) finden Sie hier: Kurs, Chart, Nachrichten, Diskussionen, Fundamentaldaten, ...https://www.facebook.com/mario.meierhof/posts/...otif_t=share_comment

hansen medical wer hier investiert ist selber schuld

cash reicht nur noch für 1-2 quartale

alle relevanten patente wurden an irsg verhoekert

der kurs verlaeuft um 1 dollar und koennte gleich die complience mit der nasdaq verlieren

insider bereiten sich schon auf ein debt to equity swap mit dem richter vor

kursziel ist 10 cents

Datum Erster Hoch Tief Schluss     Stücke Volumen
  29.08.14      1,25      1,28§1,23 1,25 $ 186.612 234 T

GrB

hansen was ist hier los
es brodelt die gerüchteküche
ich tausche meine shorts in calls

Aktienanzahl 61,1 Mio. (Stand: 11.08.12)

buran und MfG

alli ja klar 5 dallas oder aber auch 0 cent

hängt davon ab was die insider vorhaben
'
buran mk ist bei 200 mio
woher hast du deine daten

pps war 1,50 dallas am 12.08.2012

bei 61,1 mio shares ist die mk 96,6 mio dallas

Shares Outstanding5: 112.20M
    Float:§51.96M
% Held by Insiders1: 22.76%
% Held by Institutions1: 37.60%

Short % of Float (as of May 30, 2014)3: 13.60%

RTK 1,00 € RTP +4,71 Pott -30,07% ,GrB

wer hat denn da das Ei in den pott gelegt
mfg der noob und ja ich bin ein noob

bei hansen gibts nur 18 cents auf den dollar statt 25 cents.

kukk mal was du heute wieder angezettelt hast buran es ist der total crash

ausser bei hansen ah nee es ist der safe hafen huihoihiiiii

wer hat schon alles die neuen hansen bankshares hier? gedruckt von der fed

hier kann sogar der herrn asbeck beruhigt sein solar schloss parken

hansen bankshares

viele sind wohl bei 2 dallas eingestiegen
deshalb sagt niemand dass er hansen bankshares hatm von der fed geliehen und bei 10% gibts sie zurück
wer konnte auch schon ahnen dass wir auf 1 dallas fallen
ist nun der boden erreicht
ich hoffe wir wallen nicht auf 70 cents

wer oder was ist denn der neue BATS kursanzeiger ?

hansen ist kurs vor dem anstieg

ich hab einen privat telefax bekommen und meine crystalkugel glänzt

buran: nur ein börsenboard geführt von www.bundesbank.de 21:18 #1
achte er einfach auf die links
Mit freundlichen Grüssen Mario Meierhof 39517 Lüderitz Gartenstrasse 6
mariomeierhof@web.de
Tel.:039361/96548 Atelier Meierhof 039361/51273 Kuhle
gez MARIO alias buran http://www.ariva.de/…/nur-ein-boersenboard-gefuehrt-von-www…

Deutsche Bundesbank - Startseite
Die Deutsche Bundesbank ist die Zentralbank der Bundesrepublik Deutschland. Zentrales Geschäftsfeld ist die Geldpolitik des Eurosystems.
BUNDESBANK.DE
https://www.facebook.com/mario.meierhof

lange eine Ewigkeit 228.10.14 20:01 #1
Mario Meierhof
29. September um 21:38 ·
buran: nur ein börsenboard geführt von www.bundesbank.de 21:18 #1
achte er einfach auf die links
Mit freundlichen Grüssen Mario Meierhof 39517 Lüderitz Gartenstrasse 6
mariomeierhof@web.de
Tel.:039361/96548 Atelier Meierhof 039361/51273 Kuhle
gez MARIO alias buran http://www.ariva.de/…/nur-ein-boersenboard-gefuehrt-von-www…

Deutsche Bundesbank - Startseite
Die Deutsche Bundesbank ist die Zentralbank der Bundesrepublik Deutschland. Zentrales Geschäftsfeld ist die Geldpolitik des Eurosystems.
BUNDESBANK.DE
https://www.facebook.com/mario.meierhof
http://www.ariva.de/forum/...rziehungsheim-lange-eine-Ewigkeit-510117

rest in peace hansen
morgen wird verkauft
ach nee oder ein debt to equity swap
eine kleine feierlichkeit fuer den ceo fuer weihnachten
ich schenk ihm meine kohle und er verbrennt hier fuer meine aktie
gute abend medical medizin fuers armenheim
heute 30 prozent und sofort von der ezb fedconnection auf 5 verbrannt na dannnnnnnnnn mal weiter so

Wenn hereingenommene Wertpapiere aufgrund von nicht auftretender Kursentwicklungen im Bestand bleiben und nicht verkauft werden, wird hierfür der Ausdruck "Hängeposition" verwendet. http://www.ariva.de/extras/lexikon.m?begriff=Haengeposition

..yöah

Sinopharm!

www.marketwired.com/press-release/...a-nasdaq-hnsn-2004781.htm

mit der Ankündigung eines Geldsegens den Anlegern am deutschen Aktienmarkt eine riesige Freude bereitet. Bis zum Dienstagmittag stieg der DAX um 1,73 Prozent auf 11 795,04 Punkte.
Um den vollständigen Artikel zu lesen, klicken Sie bitte hier. http://www.ariva.de/news/...-Hoehenrausch-dank-EZB-Milliarden-5371418

http://www.ariva.de/news/...vestigation-of-Hansen-Medical-Inc-5725008 GrB

kein aktueller Kurs verfügbar ,GrB

kein aktueller Kurs verfügbar ,GrB

WKN: A140QP  ISIN: US4113072007  US-Symbol: HNSN  

Beiträge: 127
Zugriffe: 8.567 / Heute: 5

GrB